Mocksville, North Carolina--(Newsfile Corp. - August 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) today announced results for the second quarter ended June 30, 2024, and provided an update on recent business highlights.
Second Quarter 2024 Financial Results (compared to First Quarter 2024, except as noted)
All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis franchise in late 2023.
Net revenues increased sequentially by 22.8% to $7.9 million, compared to $6.5 million.
Gross profit was $0.6 million, compared to $(1.1) million.
Operating loss declined 53.8% to $2.0 million, compared to $4.4 million.
Net loss decreased 61.4% to $2.2 million, compared to $5.5 million.
Basic and diluted EPS improved to $(0.30), compared to $($1.72).
Adjusted EBITDA declined to a loss of $2.6 million, from a loss of $3.5 million.
"The second quarter financial results demonstrate our ongoing progress in the rapid transformation of 22nd Century's operations, including improved revenues based on many new CMO opportunities, positive gross profit, and significantly reduced operating expenses for our Company," said Larry Firestone, Chairman and CEO. "Our revenue growth from new contract volumes we have secured will continue to ramp in the latter half of fiscal 2024 as we work to achieve cash positive operations by the first quarter of 2025. Additionally, our emphasis on debt reduction and improvements to the balance sheet have allowed us to focus our cash resources on operating the business."
Second Quarter 2024 - Discussion of Product Line Net Revenues
Cigarette net revenues, including export volume, increased to $4.1 million or 8% compared to $3.8 million in the prior year comparable period on neutral volume increases. Q2 2024 cigarette sales benefitted from strong summer seasonal demand with key customers, price increases that took effect in April 2024 and a one-time Spectrum® research cigarette order which provided a $0.9 million boost.
Filtered cigars net revenues decreased to $3.3 million, compared to $3.9 million in the prior year comparable period, reflecting lower volumes as the Company continues to transition away from low or negative margin manufacturing agreements, in favor of higher margin cigarette manufacturing agreements. Additionally, price increases for certain customers took effect in April 2024.
Cigarillo distribution net revenues amounted to $0.6 million, reflective of the expanded Pinnacle branded product offerings launched in Q2 2024 with a top-five national convenience store chain.
VLN® cigarette net revenues were negligible in the second quarter, a decrease from the comparable prior year period which benefited from stocking orders with major c-stores. While the Company has secured broad distribution of its VLN® products, the sell-through has not yet materialized. The Company is making changes to rebrand and relaunch its VLN® products, which will be discussed further on the conference call noted below.
Conference Call
22nd Century will host a live webcast today at 8:00 a.m. E.T. to discuss its second quarter 2024 financial results and business highlights. The live and archived webcast will be accessible in the Events section on 22nd Century's Investor Relations website at https://ir.xxiicentury.com/events.
Summary Financial Results
(dollars in thousands, except per share data)
| Three Months Ended | |||||||||||||||
| June 30, | Change | ||||||||||||||
| 2024 | 2023 | $ | % | ||||||||||||
| Revenues, net | $ | 7,947 | $ | 8,050 | (103 | ) | (1.3 | ) | |||||||
| Gross profit (loss) | $ | 570 | $ | (961 | ) | 1,531 | (159.3 | ) | |||||||
| Operating loss | $ | (2,047 | ) | $ | (12,043 | ) | 9,996 | (83.0 | ) | ||||||
| Net loss from continuing operations | $ | (2,214 | ) | $ | (13,708 | ) | 11,494 | (83.8 | ) | ||||||
| Basic and diluted loss per common share from continuing operations | $ | (0.30 | ) | $ | (15.61 | ) | 15 | (98.1 | ) | ||||||
| Adjusted EBITDA (a) | $ | (2,589 | ) | $ | (10,251 | ) | 7,662 | 74.7 | |||||||
| Six Months Ended | |||||||||||||||
| June 30, | Change | ||||||||||||||
| 2024 | 2023 | $ | % | ||||||||||||
| Revenues, net | $ | 14,416 | $ | 16,977 | (2,561 | ) | (15.1 | ) | |||||||
| Gross profit (loss) | $ | (559 | ) | $ | (944 | ) | 385 | (40.8 | ) | ||||||
| Operating loss | $ | (6,481 | ) | $ | (22,446 | ) | 15,965 | (71.1 | ) | ||||||
| Net loss from continuing operations | $ | (7,664 | ) | $ | (24,537 | ) | 16,873 | (68.8 | ) | ||||||
| Basic and diluted loss per common share from continuing operations | $ | (1.44 | ) | $ | (28.46 | ) | 27 | (94.9 | ) | ||||||
| Adjusted EBITDA (a) | $ | (6,089 | ) | $ | (19,213 | ) | 13,124 | 68.3 | |||||||
| (a) Adjusted EBITDA is a non-GAAP financial measure. Please see "Notes Regarding Non-GAAP Financial Information" for additional information regarding our use of non-GAAP financial measures. Refer to Tables A at the end of this release for reconciliations of adjusted amounts to the closest corresponding GAAP financial measures. | |||||||||||||||
Summary Product Line Results
(in thousands)
| Three Months Ended | ||||||||||||||||||
| June 30, | ||||||||||||||||||
| 2024 | 2023 | Change | ||||||||||||||||
| $ | Cartons | $ | Cartons | $ | Cartons | |||||||||||||
| Contract Manufacturing | ||||||||||||||||||
| Cigarettes | 4,107 | 169 | 3,797 | 155 | 310 | 14 | ||||||||||||
| Filtered Cigars | 3,303 | 459 | 3,931 | 612 | (628 | ) | (153 | ) | ||||||||||
| Cigarillos | 552 | 91 | - | - | 552 | 91 | ||||||||||||
| Total Contract Manufacturing | 7,962 | 719 | 7,728 | 767 | 234 | (48 | ) | |||||||||||
| VLN®* | (15 | ) | 0 | 322 | 8 | (337 | ) | (8 | ) | |||||||||
| Total Product Line Revenues | 7,947 | 719 | 8,050 | 774 | (103 | ) | (56 | ) | ||||||||||
| *VLN® sales for the three-month period ended June 30, 2024 were negligible, offset by promotion and rebate expenses accruals. | ||||||||||||||||||
| Six Months Ended | ||||||||||||||||||
| June 30, | ||||||||||||||||||
| 2024 | 2023 | Change | ||||||||||||||||
| $ | Cartons | $ | Cartons | $ | Cartons | |||||||||||||
| Contract Manufacturing | ||||||||||||||||||
| Cigarettes | 6,867 | 260 | 8,286 | 436 | (1,419 | ) | (176 | ) | ||||||||||
| Filtered Cigars | 6,927 | 995 | 8,326 | 1,316 | (1,399 | ) | (321 | ) | ||||||||||
| Cigarillos | 552 | 91 | - | - | 552 | 91 | ||||||||||||
| Total Contract Manufacturing | 14,346 | 1,346 | 16,612 | 1,752 | (2,266 | ) | (406 | ) | ||||||||||
| VLN® | 70 | 2 | 365 | 9 | (295 | ) | (7 | ) | ||||||||||
| Total Product Line Revenues | 14,416 | 1,348 | 16,977 | 1,761 | (2,561 | ) | (413 | ) | ||||||||||
About 22nd Century Group, Inc.
22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction by offering tobacco products with 95% less nicotine, designed to improve health and wellness by helping smokers smoke less. Backed by comprehensive and extensively patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, the Company has pioneered the development of high-yield, proprietary reduced nicotine content (RNC) tobacco plants and clinically validated RNC cigarette products. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. The Company is a subsequent participating manufacturer under the Master Settlement Agreement ("MSA") and vertically integrated for the production of both its own products and contract manufacturing operations ("CMO"), which consist primarily of branded filtered cigars and conventional cigarettes.
Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.
Learn more about VLN® at tryvln.com.
Notes regarding Non-GAAP Financial Information
In addition to the Company's reported results in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the Company provides EBITDA and Adjusted EBITDA.
In order to calculate EBITDA, the Company adjusts net (loss) income by adding back interest expense (income), provision (benefit) for income taxes, and depreciation and amortization expense. Adjusted EBITDA consists of EBITDA adjusted by the Company for certain non-cash and/or non-operating expenses, including adding back equity-based employee compensation expense, restructuring and restructuring-related charges such as impairment, acquisition and transaction costs, and other unusual or infrequently occurring items, if applicable, such as inventory reserves and adjustments, gains or losses on disposal of property, plant and equipment, and gains or losses on investments.
The Company believes that the presentation of EBITDA and Adjusted EBITDA are important financial measures that supplement discussion and analysis of its financial condition and results of operations and enhances an understanding of its operating performance. While management considers EBITDA and Adjusted EBITDA to be important, these financial performance measures should be considered in addition to, but not as a substitute for or superior to, other measures of financial performance prepared in accordance with GAAP, such as operating (loss) income, net (loss) income and cash flows from operations. Adjusted EBITDA is susceptible to varying calculations and the Company's measurement of Adjusted EBITDA may not be comparable to those of other companies.
Net total debt is calculated as total principal amount of debt outstanding less cash and cash equivalents. In addition to the performance measures identified above, we believe that net total debt provides a meaningful measure of liquidity and a useful basis for assessing our ability to fund our activities, including the financing of scheduled debt repayments.
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our strategic alternatives and cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024, and in the Company's Quarterly Report filed on May 15, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
This email address is being protected from spambots. You need JavaScript enabled to view it.
214-597-8200
22nd CENTURY GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(amounts in thousands, except share and per-share data)
| June 30, | December 31, | |||||||
| 2024 | 2023 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 1,279 | $ | 2,058 | ||||
| Accounts receivable, net | 2,448 | 1,671 | ||||||
| Inventories | 2,664 | 4,346 | ||||||
| Insurance recoveries | 3,768 | 3,768 | ||||||
| GVB promissory note | 500 | 2,000 | ||||||
| Prepaid expenses and other current assets | 1,767 | 1,180 | ||||||
| Current assets of discontinued operations held for sale | 1,058 | 1,254 | ||||||
| Total current assets | 13,484 | 16,277 | ||||||
| Property, plant and equipment, net | 3,093 | 3,393 | ||||||
| Operating lease right-of-use assets, net | 1,769 | 1,894 | ||||||
| Intangible assets, net | 5,728 | 5,924 | ||||||
| Other assets | 15 | 15 | ||||||
| Total assets | $ | 24,089 | $ | 27,503 | ||||
| LIABILITIES AND SHAREHOLDERS' DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Notes and loans payable - current | $ | 877 | $ | 543 | ||||
| Current portion of long-term debt | 1,500 | 5,848 | ||||||
| Operating lease obligations | 245 | 231 | ||||||
| Accounts payable | 3,893 | 4,445 | ||||||
| Accrued expenses | 884 | 1,322 | ||||||
| Accrued litigation | 3,768 | 3,768 | ||||||
| Accrued payroll | 300 | 883 | ||||||
| Accrued excise taxes and fees | 2,510 | 2,234 | ||||||
| Deferred income | 389 | 726 | ||||||
| Other current liabilities | 309 | 1,849 | ||||||
| Current liabilities of discontinued operations held for sale | 1,397 | 3,185 | ||||||
| Total current liabilities | 16,072 | 25,034 | ||||||
| Long-term liabilities: | ||||||||
| Operating lease obligations | 1,571 | 1,698 | ||||||
| Long-term debt | 6,046 | 8,058 | ||||||
| Other long-term liabilities | 1,355 | 1,123 | ||||||
| Total liabilities | 25,044 | 35,914 | ||||||
| Shareholders' equity (deficit) | ||||||||
| Preferred stock, $.00001 par value, 10,000,000 shares authorized | ||||||||
| Common stock, $.00001 par value, 250,000,000 shares authorized | ||||||||
| Capital stock issued and outstanding: | ||||||||
| 9,272,518 common shares (2,720,437 at December 31, 2023) | ||||||||
| Common stock, par value | - | - | ||||||
| Capital in excess of par value | 384,603 | 370,297 | ||||||
| Accumulated deficit | (385,558 | ) | (378,707 | ) | ||||
| Total shareholders' deficit | (955 | ) | (8,410 | ) | ||||
| Total liabilities and shareholders' deficit | $ | 24,089 | $ | 27,503 | ||||
22nd CENTURY GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(amounts in thousands, except share and per-share data)
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Revenues, net | $ | 7,947 | $ | 8,050 | $ | 14,416 | $ | 16,977 | ||||||||
| Cost of goods sold | 3,869 | 4,682 | 8,082 | 9,407 | ||||||||||||
| Excise taxes and fees on products | 3,508 | 4,329 | 6,893 | 8,514 | ||||||||||||
| Gross (loss) profit | 570 | (961 | ) | (559 | ) | (944 | ) | |||||||||
| Operating expenses: | ||||||||||||||||
| Sales, general and administrative | 2,360 | 10,283 | 5,266 | 20,119 | ||||||||||||
| Research and development | 250 | 799 | 675 | 1,529 | ||||||||||||
| Other operating expense (income), net | 7 | - | (19 | ) | (146 | ) | ||||||||||
| Total operating expenses | 2,617 | 11,082 | 5,922 | 21,502 | ||||||||||||
| Operating loss from continuing operations | (2,047 | ) | (12,043 | ) | (6,481 | ) | (22,446 | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Other income (expense), net | 339 | (613 | ) | 339 | (768 | ) | ||||||||||
| Interest income, net | 21 | 65 | 21 | 122 | ||||||||||||
| Interest expense | (501 | ) | (1,071 | ) | (1,517 | ) | (1,399 | ) | ||||||||
| Total other expense | (141 | ) | (1,619 | ) | (1,157 | ) | (2,045 | ) | ||||||||
| Loss from continuing operations before income taxes | (2,188 | ) | (13,662 | ) | (7,638 | ) | (24,491 | ) | ||||||||
| Provision for income taxes | 26 | 46 | 26 | 46 | ||||||||||||
| Net loss from continuing operations | $ | (2,214 | ) | $ | (13,708 | ) | $ | (7,664 | ) | $ | (24,537 | ) | ||||
| Discontinued operations: | ||||||||||||||||
| Income (loss) from discontinued operations before income taxes | $ | 1,102 | $ | (6,831 | ) | $ | 813 | $ | (14,184 | ) | ||||||
| Provision (benefit) for income taxes | - | - | - | - | ||||||||||||
| Net income (loss) from discontinued operations | $ | 1,102 | $ | (6,831 | ) | $ | 813 | $ | (14,184 | ) | ||||||
| Net loss | $ | (1,112 | ) | $ | (20,539 | ) | $ | (6,851 | ) | $ | (38,721 | ) | ||||
| Deemed dividends | (445 | ) | (367 | ) | (4,034 | ) | (367 | ) | ||||||||
| Net loss available to common shareholders | $ | (1,557 | ) | $ | (20,906 | ) | $ | (10,885 | ) | $ | (39,088 | ) | ||||
| Basic and diluted loss per common share from continuing operations | $ | (0.30 | ) | $ | (15.61 | ) | $ | (1.44 | ) | $ | (28.46 | ) | ||||
| Basic and diluted loss per common share from discontinued operations | $ | 0.15 | $ | (7.78 | ) | $ | 0.15 | $ | (16.45 | ) | ||||||
| Basic and diluted loss per common share from deemed dividends | $ | (0.06 | ) | $ | (0.42 | ) | $ | (0.76 | ) | $ | (0.43 | ) | ||||
| Basic and diluted loss per common share | $ | (0.21 | ) | $ | (23.81 | ) | $ | (2.05 | ) | $ | (45.34 | ) | ||||
| Weighted average common shares outstanding - basic and diluted | 7,449,706 | 878,171 | 5,307,471 | 862,177 | ||||||||||||
| Net loss | $ | (1,112 | ) | $ | (20,539 | ) | $ | (6,851 | ) | $ | (38,721 | ) | ||||
| Other comprehensive income: | ||||||||||||||||
| Unrealized gain on short-term investment securities | - | 10 | - | 71 | ||||||||||||
| Foreign currency translation | - | 42 | - | 38 | ||||||||||||
| Reclassification of realized losses to net loss | - | 28 | - | 41 | ||||||||||||
| Other comprehensive income | - | 80 | - | 150 | ||||||||||||
| Comprehensive loss | $ | (1,112 | ) | $ | (20,459 | ) | $ | (6,851 | ) | $ | (38,571 | ) | ||||
Table A - Reconciliations of Non-GAAP Measures
(dollars in thousands, except share and per-share data)
Below is a table containing information relating to the Company's Net loss, EBITDA and Adjusted EBITDA for the three and six month periods ended June 30, 2024 and 2023, including a reconciliation of these Non-GAAP measures for such periods.
| (UNAUDITED) | ||||||||||||
| Three Months Ended | ||||||||||||
| June 30, | $ Change | |||||||||||
| 2024 | 2023 | fav / (unfav)1 | ||||||||||
| Net loss from continuing operations | $ | (2,214 | ) | $ | (13,708 | ) | $ | 11,494 | ||||
| Interest (income)/expense, net | 479 | 1,006 | (527 | ) | ||||||||
| Provision (benefit) for income taxes | 26 | 46 | (20 | ) | ||||||||
| Amortization and depreciation | 248 | 365 | (117 | ) | ||||||||
| EBITDA | $ | (1,461 | ) | $ | (12,291 | ) | $ | 10,830 | ||||
| Adjustments: | ||||||||||||
| Restructuring and impairment | (319 | ) | - | (319 | ) | |||||||
| Change in fair value of derivative liabilities | (541 | ) | - | (541 | ) | |||||||
| Change in fair value of warrant liabilities | (324 | ) | 584 | (908 | ) | |||||||
| Equity-based employee compensation expense | 56 | 1,456 | (1,400 | ) | ||||||||
| Adjusted EBITDA | $ | (2,589 | ) | $ | (10,251 | ) | $ | 7,662 | ||||
| Adjusted EBITDA loss per common share | $ | (0.35 | ) | $ | (11.67 | ) | $ | 11.33 | ||||
| Weighted average common shares outstanding - basic and diluted | 7,449,706 | 878,171 | ||||||||||
| (UNAUDITED) | ||||||||||||
| Six Months Ended | ||||||||||||
| June 30, | $ Change | |||||||||||
| 2024 | 2023 | fav / (unfav)1 | ||||||||||
| Net loss from continuing operations | $ | (7,664 | ) | $ | (24,537 | ) | $ | 16,873 | ||||
| Interest (income)/expense, net | 1,495 | 1,277 | 218 | |||||||||
| Provision (benefit) for income taxes | 26 | 46 | (20 | ) | ||||||||
| Amortization and depreciation | 514 | 726 | (212 | ) | ||||||||
| EBITDA | $ | (5,629 | ) | $ | (22,488 | ) | $ | 16,859 | ||||
| Adjustments: | ||||||||||||
| Restructuring and impairment | (345 | ) | - | (345 | ) | |||||||
| Inventory write-down | 431 | - | 431 | |||||||||
| Change in fair value of derivative liabilities | (459 | ) | - | (459 | ) | |||||||
| Change in fair value of warrant liabilities | (324 | ) | 723 | (1,047 | ) | |||||||
| Equity-based employee compensation expense | 237 | 2,552 | (2,315 | ) | ||||||||
| Adjusted EBITDA | $ | (6,089 | ) | $ | (19,213 | ) | $ | 13,124 | ||||
| Adjusted EBITDA loss per common share | $ | (1.15 | ) | $ | (22.28 | ) | $ | 21.14 | ||||
| Weighted average common shares outstanding - basic and diluted | 5,307,471 | 862,177 | ||||||||||
| 1Fav = Favorable variance, which increases EBITDA and Adjusted EBITDA; Unfav = unfavorable variance, which reduces EBITDA and Adjusted EBITDA | ||||||||||||
Table B: Net Total Debt Reconciliation
(dollars in thousands)
| June 30, | December 31, | |||||||
| 2024 | 2023 | |||||||
| Total debt | $ | 7,546 | $ | 13,906 | ||||
| Add: debt discounts and deferred issuance costs included in total debt | 779 | 1,453 | ||||||
| Total principal amount of debt outstanding | 8,325 | 15,359 | ||||||
| Less: Cash and cash equivalents | 1,279 | 2,058 | ||||||
| Net total debt (Non-GAAP) | $ | 7,046 | $ | 13,301 | ||||
| Last Trade: | US$5.12 |
| Daily Change: | 0.28 5.79 |
| Daily Volume: | 35,474 |
| Market Cap: | US$2.830M |
November 12, 2024 July 10, 2024 | |
Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...
CLICK TO LEARN MORE
Surf Air Mobility is a regional air mobility platform expanding the category of regional air travel to reinvent flying through the power of electrification. In an effort to substantially reduce the cost and environmental impact of...
CLICK TO LEARN MORE